BRCA1/2 mutations are present in 5%–15% of all breast and ovarian cancers [3,4,5] and have been found in other hereditary diseases [23,24,25,26], in the absence of homolous recombination, cells are more vulnerable to genomic instability. Here, BRCA1 is linked to ovarian cancer.